Center for Interventions, Treatment, and Addiction Research, Department of Community Health, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA.
J Psychoactive Drugs. 2010 Dec;42(4):435-45. doi: 10.1080/02791072.2010.10400706.
This study examined sociodemographic and drug-related predictors of depressive symptoms among a rural, multistate sample of not-in-treatment stimulant drug users (n=710). Participants were recruited using respondent-driven sampling in Ohio, Arkansas, and Kentucky. The Patient Health Questionnaire (PHQ-9) was used to measure symptoms of depression. Moderate to severe depressive symptomatology was reported by 43.0% of the sample. Cumulative logistic regression analysis showed that daily and nondaily crack use as well as the daily use of cocaine HCl increased the odds of depressive symptoms. Methamphetamine use had no significant association with depression. The daily use of marijuana, the illicit use of tranquilizers, light/moderate cigarette smoking, and injection drug use also increased the risk of depressive symptoms. Living in Kentucky or Ohio (compared to Arkansas), having unstable living arrangements, and being White, female, and older were related to higher odds of depressive symptoms. These results suggest that a host of drug and nondrug factors need to be considered when addressing depressive symptoms in stimulant users.
本研究考察了农村多州未接受治疗的兴奋剂药物使用者(n=710)中社会人口统计学和与药物相关的抑郁症状预测因素。参与者是在俄亥俄州、阿肯色州和肯塔基州通过回应者驱动抽样招募的。使用患者健康问卷(PHQ-9)来衡量抑郁症状。样本中 43.0%报告有中度至重度抑郁症状。累积逻辑回归分析表明,每日和非每日吸食快克可卡因以及每日吸食可卡因 HCl 会增加抑郁症状的几率。甲基苯丙胺使用与抑郁无关。大麻的每日使用、非法使用镇静剂、轻度/中度吸烟和注射毒品使用也会增加抑郁症状的风险。居住在肯塔基州或俄亥俄州(与阿肯色州相比)、居住安排不稳定、以及为白种人、女性和年龄较大与更高的抑郁症状几率相关。这些结果表明,在解决兴奋剂使用者的抑郁症状时,需要考虑一系列药物和非药物因素。